Immix Biopharma
IMMX
IMMX
28 hedge funds and large institutions have $5.43M invested in Immix Biopharma in 2023 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.96% more ownership
Funds ownership: 2.06% → 4.02% (+2%)
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$710K | |
| 2 | +$690K | |
| 3 | +$375K | |
| 4 |
Renaissance Technologies
New York
|
+$224K |
| 5 |
Morgan Stanley
New York
|
+$221K |
Top Sellers
| 1 | -$174K | |
| 2 | -$27.7K | |
| 3 | -$3.84K | |
| 4 |
BlackRock
New York
|
-$1.93K |